PPBT
Purple Biotech
PPBT
PPBT
3 hedge funds and large institutions have $15K invested in Purple Biotech in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
$3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$11K |
| 3 |
Citigroup
New York
|
$1K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $11K | +$1.83K | +2 | +20% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $3K | +$3K | +4 | New |
|
|
3
Citigroup
New York
| $1K | +$1K | +1 | New |
|